EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Varenicline Treatment for Waterpipe Smoking Cessation

Hassan A Chami, Nour Zaouk, Maha Makki, Hani Tamim, Monique Shaya, Farid Talih

Nicotine & Tobacco Research · 2023

DOI: 10.1093/ntr/ntac162 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nicotine & Tobacco Research, 2023. Verfasst von Hassan A Chami und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, American University of Beirut, Beirut, Lebanon. Hauptthemen laut MEDLINE: Smoking Cessation, Water Pipe Smoking. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Pfizer Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Waterpipe smoking is increasing worldwide with no proven interventions for cessation. We compared abstinence rates with 12-week varenicline therapy versus placebo among habitual waterpipe smokers willing to quit.

Methods

This double-blind placebo-controlled single-center trial, randomized waterpipe smokers from Lebanon who did not smoke other tobacco products to receive varenicline or placebo for 12 weeks. All participants also received three structured 30-minute individual behavioral intervention sessions. The primary outcome was repeated point prevalence abstinence assessed by self-report and verified by exhaled carbon monoxide three times during 12 weeks and analyzed with the intention to treat. End of treatment urine cotinine, weight, blood pressure, anxiety, depression, withdrawal, and adverse symptoms were also assessed.

Results

In total, 152 waterpipe smokers (mean age 38 years [SD = 13], 39% females) willing to quit, who smoked waterpipe exclusively (average 2.3 per day [SD = 1.6] for 16.8 years [SD = 10.8]) were randomized. Seventy-nine participants (52%) with any missing abstinence assessment were considered to have relapsed. Repeat point prevalence abstinence rate was numerically higher among the varenicline group compared to placebo, but the difference did not reach statistical significance when assessed by self-report (16.9 vs. 13.6%, respectively, p = .6) and when further verified by exhaled carbon monoxide (14.1% vs. 9.9%, respectively, p = .4). Abstinence rates were similar in both groups when further verified by urine cotinine at end of treatment. No serious adverse events were reported, adverse symptoms and other outcomes were similar in the varenicline and placebo arms.

Conclusions

Varenicline for 12 weeks was not more effective than placebo to achieve abstinence among daily waterpipe smokers.

Implications

Varenicline in combination with a behavioral intervention did not significantly enhance the quit rate among exclusive waterpipe smokers compared to behavioral intervention plus placebo. We experienced difficulty enrolling exclusive waterpipe smokers willing to quit and observed high dropout rates among participants demonstrating the difficulties of waterpipe smoking cessation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationWater Pipe SmokingFemaleHumansAdultMaleVareniclineCarbon MonoxideCotinineNicotinic Agonists

Substanzen

VareniclineCarbon MonoxideCotinineNicotinic Agonists

Autor:innen und Institutionen

  • School of Medicine, American University of Beirut, Beirut, Lebanon.
  • Department of Medicine, Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • School of Public Health, American University of Beirut, Beirut, Lebanon.

Förderung

  • Pfizer Inc

Zitieren

APA

Chami, H. A., Zaouk, N., Makki, M., Tamim, H., Shaya, M., & Talih, F. (2023). Varenicline Treatment for Waterpipe Smoking Cessation. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntac162

Vancouver

Chami HA, Zaouk N, Makki M, Tamim H, Shaya M, Talih F. Varenicline Treatment for Waterpipe Smoking Cessation. Nicotine & Tobacco Research. 2023. doi:10.1093/ntr/ntac162

BibTeX
@article{Chami2023,
  author = {Chami, Hassan A and Zaouk, Nour and Makki, Maha and Tamim, Hani and Shaya, Monique and Talih, Farid},
  title = {Varenicline Treatment for Waterpipe Smoking Cessation},
  journal = {Nicotine & Tobacco Research},
  year = {2023},
  doi = {10.1093/ntr/ntac162}
}
Kostenlos starten →